ARGNANI, Rafaela
 Distribuzione geografica
Continente #
NA - Nord America 2.150
EU - Europa 443
AS - Asia 394
AF - Africa 2
OC - Oceania 2
SA - Sud America 2
Totale 2.993
Nazione #
US - Stati Uniti d'America 2.148
CN - Cina 245
UA - Ucraina 153
TR - Turchia 106
GB - Regno Unito 71
DE - Germania 60
IT - Italia 52
FI - Finlandia 31
SG - Singapore 30
SE - Svezia 25
AT - Austria 18
BE - Belgio 14
FR - Francia 9
IR - Iran 4
PL - Polonia 4
CA - Canada 2
ES - Italia 2
ID - Indonesia 2
IN - India 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BG - Bulgaria 1
BR - Brasile 1
CH - Svizzera 1
DK - Danimarca 1
EG - Egitto 1
IL - Israele 1
MA - Marocco 1
NZ - Nuova Zelanda 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
VE - Venezuela 1
VN - Vietnam 1
Totale 2.993
Città #
Fairfield 281
Woodbridge 261
Houston 235
Jacksonville 161
Chandler 143
Ann Arbor 134
Ashburn 134
Cambridge 112
Wilmington 112
Seattle 111
Beijing 77
Izmir 62
Nanjing 56
New York 46
Princeton 35
San Diego 32
Boardman 18
Shanghai 18
Singapore 18
Vienna 18
Shenyang 17
Brussels 14
Hebei 12
Tianjin 11
Ferrara 10
Nanchang 10
Milan 9
Jiaxing 8
Norwalk 8
Changsha 7
San Mateo 7
Falls Church 6
Ningbo 6
Verona 6
Washington 6
Auburn Hills 5
Jinan 5
Orange 5
Augusta 4
Dearborn 4
Los Angeles 4
Mountain View 4
Philadelphia 4
Taizhou 4
Warsaw 4
Ardabil 3
Indiana 3
Kunming 3
Pieve Emanuele 3
Redwood City 3
Acton 2
Bologna 2
Chicago 2
Genoa 2
Guangzhou 2
Haikou 2
Hangzhou 2
Hounslow 2
Jakarta 2
Leawood 2
London 2
Toronto 2
Valeggio sul Mincio 2
Zhengzhou 2
Allahabad 1
Auckland 1
Bangalore 1
Brugg 1
Buffalo 1
Cairo 1
Castelfranco Emilia 1
Des Moines 1
Dong Ket 1
Dubai 1
Forest City 1
Fort Worth 1
General Trias 1
Guardiagrele 1
Hicksville 1
Lyon 1
Madrid 1
Monmouth Junction 1
Napoli 1
Negar 1
Paris 1
Piracuruca 1
Rabat 1
Sofia 1
Tacoma 1
Taiyuan 1
Tel Aviv 1
Turin 1
Vasto 1
Velletri 1
Wandsworth 1
Wirral 1
Totale 2.319
Nome #
Effects of defective herpes simplex vectors expressing neurotrophic factors on the proliferation and differentiation of nervous cells in vivo 136
Inhibition of herpes simplex virus types 1 and 2 in vitro infection by sulfated derivatives of Escherichia coli K5 polysaccharide 124
Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity 122
Characterization of herpes simplex virus type 1 recombinants that express and incorporate high levels of HCV E2-gC chimeric proteins 120
Characterization of herpes simplex virus 1 strains as platforms for the development of oncolytic viruses against liver cancer 120
HSV-1-derived recombinant and amplicon vectors for gene transfer and gene therapy 115
Red blood cells as delivery system for recombinant HSV-1 glycoprotein B: Immunogenicity and protection in mice 113
Immunotherapeutic activity of a recombinant combined gB-gD-gE vaccine against recurrent HSV-2 infections in a guinea pig model 109
HSV as a vector in vaccine development and gene therapy 107
null 107
Replication-competent herpes simplex vectors: design and applications 105
Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivo 103
Intranasal immunization in mice with non-ionic surfactants vesicles containing HSV immunogens: a preliminary study as possible vaccine against genital herpes 102
Mice genetic immunization with plasmid DNA encoding a secreted form of HSV-1 gB induces a protective immune response against herpes simplex virus type 1 infection 101
Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide 98
HSV as a vector in vaccine development and gene therapy 97
Herpesvirus-based vectors for gene transfer, gene therapy and the development of novel vaccines 94
Role of Herpes Simplex Envelope Glycoprotein B and Toll-Like Receptor 2 in Ocular Inflammation: An ex vivo Organotypic Rabbit Corneal Model 92
Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread 91
HERPES-SIMPLEX VIRUS TYPE-1 (HSV-1) URACIL-DNA GLYCOSYLASE - FUNCTIONAL EXPRESSION IN ESCHERICHIA-COLI, BIOCHEMICAL-CHARACTERIZATION, AND SELECTIVE-INHIBITION BY 6-(P-N-OCTYLANILINO)URACIL 88
null 88
Cationic liposomes as carriers for ocular administration of anti herpetic peptides 84
Virus erpetici come vettori vaccinali 83
null 81
In vitro antiviral activity of Emblica officinalis extracts and GC/MS identified compounds 78
HERPES-SIMPLEX VIRUS TYPE-1 URACIL-DNA GLYCOSYLASE - CLONING AND CHARACTERIZATION 65
Expression of the herpes simplex virus type 1 glycoprotein E in human cells and in Escherichia coli: Protection studies against lethal viral infection in mice 64
In vitro antiviral activity of Emblica officinalis extracts and GC/MS identified compounds 61
Poster: Herpes simplex vaccine vector co-expressing fused Mycobacterium Tuberculosis immunogens and Tat adjuvant enhances cellular and humoral responses in Balb/c mice 60
Gene therapy of the nervous system by herpes virus vectors 56
Immunotherapeutic activity of a recombinant glycoprotein vaccine aganst recurrent genital herpes in a guinea pig model. 54
Liposome as antiherpetic peptide vehicle 45
Use of herpes simplex virus type 1-based amplicon vector for delivery of small interfering RNA 21
APP processing induced by herpes simplex virus type 1 (HSV-1) yields several APP fragments in human and rat neuronal cells 20
HSV Recombinant Vectors for Gene Therapy 18
Totale 3.022
Categoria #
all - tutte 11.253
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 596
Totale 11.849


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020750 115 22 39 103 49 68 63 75 50 72 74 20
2020/2021420 39 35 34 43 17 40 14 53 5 54 62 24
2021/2022386 26 34 21 6 17 10 22 14 15 26 38 157
2022/2023339 35 14 29 44 48 64 9 22 41 2 19 12
2023/2024216 20 24 7 12 16 66 11 11 3 2 6 38
2024/20252 2 0 0 0 0 0 0 0 0 0 0 0
Totale 3.022